Consistent with this, in our recent examination of the activity of the MDM2i NVP-CGM097 in ER+ breast cancer models, we were able to observe accumulation of cells in both the G1 and G2/M phases of the cell cycle after p53 activation (29). Here, TP53 is linked to breast cancer.